HomeHealthcare & Life SciencesBiotechnology Preimplantation Genetic Testing Market

Saudi Arabia Preimplantation Genetic Testing Market Size & Outlook, 2025-2033


Saudi Arabia Preimplantation Genetic Testing Market Insights

  • Based on Reed Intelligence findings, the Saudi Arabia Preimplantation Genetic Testing Market reached USD 13.67 Million in 2024 and is estimated to attain USD 25.73 Million by 2033.
  • From 2026 to 2033, the Saudi Arabia market is expected to grow at a steady CAGR of 7.31%.
  • Within the By Procedure category, Preimplantation Genetic Screening (PGS) dominated in 2024 in terms of market size contribution.
  • Over the forecast period, Preimplantation Genetic Diagnosis (PGD) is forecasted to deliver the fastest growth, positioning it as the most lucrative By Procedure segment.

Other Key Findings


  • In 2024, Saudi Arabia accounted for 1.61% of the global Preimplantation Genetic Testing Market size.
  • By 2033, United States is expected to lead the global Preimplantation Genetic Testing Market in terms of market size.
  • Within Middle East and Africa, United Arab Emirates is projected to dominate the regional Preimplantation Genetic Testing Market size by 2033.
  • South Africa is identified as the fastest-growing market in Middle East and Africa, anticipated to reach USD 11.51 Million by 2033.

Report Summary

Report Scope Details
Base Year for Study 2024
Study Period 2021-2033
Historical Period 2021-2023
Forecast Period 2025-2033
Market Size In 2024 USD 13.67 Million
Market Size In 2033 USD 25.73 Million
Largest segment Preimplantation Genetic Screening (PGS)
Units Revenue in USD Million
CAGR 7.31% (2025-2033)
Segmnetation Covered
By Procedure
  1. Preimplantation Genetic Screening (PGS)
  2. Preimplantation Genetic Diagnosis (PGD)
By Product
  1. Reagents and Consumables
  2. Instruments
  3. Software
By Technology
  1. Next-Generation Sequencing (NGS)
  2. Polymerase Chain Reaction (PCR)
  3. Fluorescent In Situ Hybridisation (FISH)
  4. Others
By Application
  1. Chromosomal Abnormalities
  2. Aneuploidy Screening
  3. X-linked Diseases
  4. Embryo Testing
  5. Human Leukocyte Antigen (HLA) Typing
  6. Others
By End-User
  1. Hospitals
  2. Fertility Centres
  3. Diagnostic Centres
  4. Research Centres and Academic Labs
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Related Reports